Omalizumab

Source:
British Association of Dermatologists - BAD
Publication date:
08 March 2018

Abstract

Omalizumab is a drug that has been specially designed to mimic normal human molecules, and for this reason is classified as a biologic drug. It interferes with natural antibodies called IgEs in the body and prevents them from causing histamine release from certain cells.